Literature DB >> 15196598

The role of personality disorders on drug dependence treatment outcomes following inpatient detoxification.

G Haro1, C Mateu, J Martínez-Raga, J C Valderrama, M Castellano, G Cervera.   

Abstract

AIMS: The present 6 month follow-up study was conducted to investigate the possible influence of comorbid personality disorders on drug treatment, as well as associated psychopathology and HIV-related risk behaviors outcomes. SUBJECTS AND METHODS: Data were collected initially from a consecutive sample of 74 patients with a diagnosis of opiate abuse or dependence, admitted for inpatient detoxification. RESULT: During intake, 80.9% of patients reported at least one HIV-related risk behavior in the previous 6 months. Not using condoms during sexual intercourse was the most common and the only risk behavior that showed a statistically significant reduction over the follow-up period. A total of 58.1% of subjects had at least one personality disorder (PD). Borderline PD was the most prevalent. However, antisocial PD was the only PD that influenced substance use outcomes. The presence of this diagnosis increased the chance of worse opiate use outcomes, but decreased likelihood of not using condoms. Patients with low obsessive-compulsive PD dimensional scores showed a significant increase in the number of risk behaviors. However, these influences were only seen at the 3-month follow-up assessment.
CONCLUSIONS: These results suggest that personality disorders need to be considered when planning effective interventions for opiate dependent individuals and when preparing and evaluating HIV risk-reduction interventions, particularly for the more severe substance dependent patients.

Entities:  

Mesh:

Year:  2004        PMID: 15196598     DOI: 10.1016/j.eurpsy.2004.04.004

Source DB:  PubMed          Journal:  Eur Psychiatry        ISSN: 0924-9338            Impact factor:   5.361


  6 in total

1.  Personality disorders and the 3-year course of alcohol, drug, and nicotine use disorders.

Authors:  Deborah Hasin; Miriam C Fenton; Andrew Skodol; Robert Krueger; Katherine Keyes; Timothy Geier; Eliana Greenstein; Carlos Blanco; Bridget Grant
Journal:  Arch Gen Psychiatry       Date:  2011-11

2.  Influence of Psychiatric and Personality Disorders on Smoking Cessation Among Individuals in Opiate Dependence Treatment.

Authors:  Nina A Cooperman; Shou-En Lu; Kimber P Richter; Steven L Bernstein; Jill M Williams
Journal:  J Dual Diagn       Date:  2016-04-11

Review 3.  Treatment of patients comorbid for addiction and other psychiatric disorders.

Authors:  Kathleen T Brady; Marcia L Verduin; Bryan K Tolliver
Journal:  Curr Psychiatry Rep       Date:  2007-10       Impact factor: 5.285

4.  Suboxone Treatment and Recovery Trial (STAR-T): Study Protocol for a Randomised Controlled Trial of Opioid Medication Assisted Treatment with Adjunctive Medication Management Using Therapeutic Drug Monitoring and Contingency Management.

Authors:  Hesham Elarabi; Abuelgasim Elrasheed; Ahmed Ali; Mansour Shawky; Nael Hasan; Tarek A Gawad; Abdu Adem; John Marsden
Journal:  J Addict       Date:  2019-03-05

5.  In-depth study of personality disorders in first-admission patients with substance use disorders.

Authors:  Anne-Marit Langås; Ulrik Fredrik Malt; Stein Opjordsmoen
Journal:  BMC Psychiatry       Date:  2012-10-29       Impact factor: 3.630

6.  Character pathology and neuropsychological test performance in remitted opiate dependence.

Authors:  James M Prosser; Daniel Eisenberg; Emily E Davey; Matthew Steinfeld; Lisa J Cohen; Edythe D London; Igor I Galynker
Journal:  Subst Abuse Treat Prev Policy       Date:  2008-11-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.